is trulicity a glp 1 med Diabetes New Zealand GLP-1 Medications for Weight Loss

Public reimbursement accounts for only 15% of the market, primarily covering patients with severe obesity and documented metabolic complications

Product selection strategy Focus on products with demonstrated quality

Following the dose-escalation schedule in the product SmPC is important to minimise these effects, and several practical strategies can help manage digestive symptoms effectively

At LIVation, we are proud to have offered a variety of different weight loss solutions to our clients

Published Phase 2 data (NEJM, 2023) showed retatrutide achieving up to 24.2% mean weight reduction at 48 weeks exceeding outcomes seen with dual GLP-1/GIP agonists

instead, they recommend taking research-based GLP-1 medications that follow the approved dosage protocols approved by the FDA